rs73938538

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005559.4(LAMA1):​c.4026T>G​(p.Val1342Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 1,612,296 control chromosomes in the GnomAD database, including 10,731 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2427 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8304 hom. )

Consequence

LAMA1
NM_005559.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.446

Publications

16 publications found
Variant links:
Genes affected
LAMA1 (HGNC:6481): (laminin subunit alpha 1) This gene encodes one of the alpha 1 subunits of laminin. The laminins are a family of extracellular matrix glycoproteins that have a heterotrimeric structure consisting of an alpha, beta and gamma chain. These proteins make up a major component of the basement membrane and have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Mutations in this gene may be associated with Poretti-Boltshauser syndrome. [provided by RefSeq, Sep 2014]
LAMA1 Gene-Disease associations (from GenCC):
  • ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 18-7008584-A-C is Benign according to our data. Variant chr18-7008584-A-C is described in ClinVar as Benign. ClinVar VariationId is 1300106.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.446 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA1NM_005559.4 linkc.4026T>G p.Val1342Val synonymous_variant Exon 28 of 63 ENST00000389658.4 NP_005550.2 P25391

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA1ENST00000389658.4 linkc.4026T>G p.Val1342Val synonymous_variant Exon 28 of 63 1 NM_005559.4 ENSP00000374309.3 P25391
LAMA1ENST00000579014.5 linkn.5041T>G non_coding_transcript_exon_variant Exon 27 of 62 2

Frequencies

GnomAD3 genomes
AF:
0.154
AC:
23366
AN:
152028
Hom.:
2420
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.292
Gnomad AMI
AF:
0.181
Gnomad AMR
AF:
0.138
Gnomad ASJ
AF:
0.124
Gnomad EAS
AF:
0.105
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.110
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.0884
Gnomad OTH
AF:
0.136
GnomAD2 exomes
AF:
0.122
AC:
30789
AN:
251384
AF XY:
0.118
show subpopulations
Gnomad AFR exome
AF:
0.298
Gnomad AMR exome
AF:
0.157
Gnomad ASJ exome
AF:
0.124
Gnomad EAS exome
AF:
0.106
Gnomad FIN exome
AF:
0.117
Gnomad NFE exome
AF:
0.0916
Gnomad OTH exome
AF:
0.107
GnomAD4 exome
AF:
0.100
AC:
146493
AN:
1460150
Hom.:
8304
Cov.:
33
AF XY:
0.100
AC XY:
72634
AN XY:
726418
show subpopulations
African (AFR)
AF:
0.303
AC:
10149
AN:
33458
American (AMR)
AF:
0.156
AC:
6997
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
3274
AN:
26118
East Asian (EAS)
AF:
0.0858
AC:
3403
AN:
39674
South Asian (SAS)
AF:
0.120
AC:
10319
AN:
86240
European-Finnish (FIN)
AF:
0.117
AC:
6255
AN:
53368
Middle Eastern (MID)
AF:
0.125
AC:
720
AN:
5764
European-Non Finnish (NFE)
AF:
0.0891
AC:
98935
AN:
1110490
Other (OTH)
AF:
0.107
AC:
6441
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
7009
14018
21027
28036
35045
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3884
7768
11652
15536
19420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.154
AC:
23407
AN:
152146
Hom.:
2427
Cov.:
32
AF XY:
0.153
AC XY:
11406
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.292
AC:
12127
AN:
41472
American (AMR)
AF:
0.137
AC:
2101
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
429
AN:
3470
East Asian (EAS)
AF:
0.105
AC:
543
AN:
5172
South Asian (SAS)
AF:
0.112
AC:
540
AN:
4822
European-Finnish (FIN)
AF:
0.110
AC:
1164
AN:
10604
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.0883
AC:
6007
AN:
68008
Other (OTH)
AF:
0.136
AC:
286
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
925
1850
2776
3701
4626
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.116
Hom.:
748
Bravo
AF:
0.164
Asia WGS
AF:
0.112
AC:
389
AN:
3478
EpiCase
AF:
0.0878
EpiControl
AF:
0.0916

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25668194) -

Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.14
DANN
Benign
0.72
PhyloP100
-0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73938538; hg19: chr18-7008583; COSMIC: COSV67533815; API